Article Details
Retrieved on: 2020-12-11 15:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
True, the data put ublituximab on a collision course with <b>Roche's</b> juggernaut Ocrevus, which derives much of its fame from activity in primary ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here